Kolexia
Christophe Olivier Médecine générale
Christophe Olivier
Médecine générale
Cabinet libéral
Bidart, France
19 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies de von Willebrand Hémorragie Hémophilie A Maladie de von Willebrand de type 3 Maladie de von Willebrand de type 2 {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Denis Celine
Denis Celine
Cabinet libéral, Paris, France
Casari Capucine
Casari Capucine
N/A, Lieu inconnu
Susen Sophie
Susen Sophie
Centre de Biologie - Pathologie, Lille, France
Jeanpierre-Tomolillo Emmanuelle
Jeanpierre-Tomolillo Emmanuelle
Hôpital Albert Calmette, Lille, France

Industries

Voir plus
MSD
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Domain-specific nanobodies distinguish intact and proteolyzed forms of von Willebrand factor in congenital von Willebrand disease
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Unique humanized mouse models of von Willebrand disease to implement the need for innovative therapeutic strategies
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Differences in bleeding profiles and venous clot structures between emicizumab and factor VIII-treated mice
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Emicizumab ameliorates hemostasis in von Willebrand Disease type 3 but not type 2A murine models
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
44 Transplacental Delivery of Maternal FVIII for Induction of FVIII-Specific Immune Tolerance
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Transplacental Delivery of Maternal Factor VIII for Induction of Immune Tolerance to Therapeutic Factor VIII
Abstracts of the ISTH 2020 Virtual Congress of the International Society on Thrombosis and Haemostasis, July 12–14, 2020   11 août 2020
Successful Non-surgical Management and Use of Thrombopoietin Receptor Agonist in a Case of Spleen Injury in a Young Girl with von Willebrand Disease Type 2B
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
Targeting Protease Nexin-1, a Natural Anticoagulant, to Control Bleeding in Hemophilia A
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
Thrombin-mediated Activation of Factor VIII is Insufficient to Produce All Necessary Cofactor Activity in vivo
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
Questions and answers on gene therapy for persons living with a rare bleeding disorder: Methodology and results to build knowledge in our community
Invited Presentation Summaries and Submitted Abstracts of the WFH 2018 World Congress   10 mai 2018